CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 29 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $995 | +82.2% | 2,250 | -9.5% | 0.00% | – |
| Q4 2022 | $546 | – | 2,485 | +72.7% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 1,439 | -0.1% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 1,440 | +1.1% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 1,424 | +0.1% | 0.00% | – |
| Q4 2021 | $1,000 | -97.7% | 1,423 | -91.8% | 0.00% | – |
| Q3 2021 | $43,000 | +975.0% | 17,415 | +1177.7% | 0.00% | – |
| Q2 2021 | $4,000 | -90.2% | 1,363 | -88.5% | 0.00% | – |
| Q1 2021 | $41,000 | -76.8% | 11,831 | -68.2% | 0.00% | – |
| Q4 2020 | $177,000 | +11.3% | 37,235 | +13.3% | 0.00% | – |
| Q3 2020 | $159,000 | +25.2% | 32,873 | -15.5% | 0.00% | – |
| Q2 2020 | $127,000 | -21.6% | 38,920 | +23.2% | 0.00% | – |
| Q1 2020 | $162,000 | -69.5% | 31,600 | -72.9% | 0.00% | – |
| Q4 2019 | $532,000 | -73.3% | 116,733 | -64.2% | 0.00% | -100.0% |
| Q3 2019 | $1,995,000 | -0.5% | 326,105 | -1.0% | 0.00% | 0.0% |
| Q2 2019 | $2,006,000 | +16.5% | 329,377 | +6.2% | 0.00% | 0.0% |
| Q1 2019 | $1,722,000 | +3.5% | 310,225 | +5.5% | 0.00% | 0.0% |
| Q4 2018 | $1,664,000 | +9.6% | 294,025 | +103.4% | 0.00% | – |
| Q3 2018 | $1,518,000 | +1.5% | 144,550 | +7.3% | 0.00% | – |
| Q2 2018 | $1,496,000 | +32.9% | 134,750 | -4.3% | 0.00% | – |
| Q1 2018 | $1,126,000 | +74.3% | 140,750 | +78.7% | 0.00% | – |
| Q4 2017 | $646,000 | +36.6% | 78,750 | +3.3% | 0.00% | – |
| Q3 2017 | $473,000 | +5.3% | 76,250 | +2.8% | 0.00% | – |
| Q2 2017 | $449,000 | +77.5% | 74,186 | +55.4% | 0.00% | – |
| Q1 2017 | $253,000 | +79.4% | 47,750 | +130.1% | 0.00% | – |
| Q4 2016 | $141,000 | +1466.7% | 20,750 | +1560.0% | 0.00% | – |
| Q3 2016 | $9,000 | -10.0% | 1,250 | 0.0% | 0.00% | – |
| Q2 2016 | $10,000 | +42.9% | 1,250 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q4 2015 | $7,000 | +40.0% | 1,250 | -8.1% | 0.00% | – |
| Q3 2015 | $5,000 | -16.7% | 1,360 | +8.8% | 0.00% | – |
| Q2 2015 | $6,000 | -40.0% | 1,250 | -50.0% | 0.00% | – |
| Q1 2015 | $10,000 | +100.0% | 2,500 | +100.0% | 0.00% | – |
| Q4 2014 | $5,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q3 2014 | $5,000 | +25.0% | 1,250 | 0.0% | 0.00% | – |
| Q2 2014 | $4,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q1 2014 | $4,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q4 2013 | $4,000 | -20.0% | 1,250 | 0.0% | 0.00% | – |
| Q3 2013 | $5,000 | -16.7% | 1,250 | 0.0% | 0.00% | – |
| Q2 2013 | $6,000 | – | 1,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |